KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Long-Term Deferred Tax (2019 - 2025)

GoodRx Holdings' Long-Term Deferred Tax history spans 6 years, with the latest figure at $69.1 million for Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax rose 4.83% year-over-year to $69.1 million; the TTM value through Sep 2025 reached $69.1 million, up 4.83%, while the annual FY2024 figure was $77.2 million, 18.25% up from the prior year.
  • Long-Term Deferred Tax for Q3 2025 was $69.1 million at GoodRx Holdings, down from $77.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $77.2 million in Q4 2024 and bottomed at $13.0 million in Q2 2021.
  • The 4-year median for Long-Term Deferred Tax is $65.3 million (2023), against an average of $58.1 million.
  • The largest annual shift saw Long-Term Deferred Tax soared 2616.3% in 2021 before it rose 4.12% in 2024.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $45.8 million in 2021, then surged by 42.43% to $65.3 million in 2023, then rose by 18.25% to $77.2 million in 2024, then fell by 10.48% to $69.1 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Long-Term Deferred Tax are $69.1 million (Q3 2025), $77.2 million (Q2 2025), and $77.2 million (Q1 2025).